Hongwei Wang

Toll-Like Receptor Polymorphisms and Susceptibility to Urinary Tract Infections in Adult Women

Thomas R. Hawn, Delia Scholes, Shuying S. Li et al. · PLoS ONE · 2009 · 204 citations · Full text

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial

Miao‐Zhen Qiu, Do‐Youn Oh, Ken Kato et al. · BMJ · 2024 · 195 citations · Full text

The Cathepsin K Inhibitor Odanacatib Suppresses Bone Resorption in Women With Breast Cancer and Established Bone Metastases: Results of a 4-Week, Double-Blind, Randomized, Controlled Trial

Anders Bonde Jensen, Christopher Wynne, Guillermo Ramírez et al. · Clinical Breast Cancer · 2010 · 143 citations

Bone Disease, Breast Oncology, Medicine +8

Relation of Childhood Risk Factors to Left Ventricular Hypertrophy (Eccentric or Concentric) in Relatively Young Adulthood (from the Bogalusa Heart Study)

Ahmet Toprak, Hongwei Wang, Wei Chen et al. · The American Journal of Cardiology · 2008 · 99 citations

Heart Failure, Cardiovascular Disease, Pediatric Heart Disease +13

Rationale 305: Phase 3 study of tislelizumab plus chemotherapy vs placebo plus chemotherapy as first-line treatment (1L) of advanced gastric or gastroesophageal junction adenocarcinoma (GC/GEJC).

Markus Moehler, Ken Kato, Hendrik‐Tobias Arkenau et al. · Journal of Clinical Oncology · 2023 · 76 citations

Esophageal Cancer, Cancer Management, Immunology +22